In <i>H pylori</i> infection, vonoprazan plus high-dose amoxicillin was noninferior to B-quadruple therapy for eradication.
Where this comes from
- Record sourced from PubMed, PMID 37126819.
- Also identified by DOI 10.7326/J23-0028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Qian HS, Li WJ, Dang YN, et al. <b>Ten-day vonoprazan-amoxicillin dual therapy as a first-line treatment of <i>Helicobacter pylori</i> infection compared with bismuth-containing quadruple therapy.</b> Am J Gastroenterol. 2023;118:627-634. 36729890.
Medical subject headings
- Helicobacter Infections
- Helicobacter pylori